Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

CytomX Therapeutics, Inc. CTMX

Healthcare  —  Biotechnology
2.70 (0.05) (1.82%) as of 25 Sep
Market cap
$599.2M
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)
Download Excel — free account

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

 143.63 137.05 346.71 331.20
Receivables 1.63 2.01 0.65 37.49
Total current assets 149.22 143.92 353.10 373.16
Property, Plant, Equpment (Net) 1.72 1.30 1.09 1.08
Goodwill and Intangible Assets (Total) 1.42 1.39 1.35 1.31
Long-term assets (Other) 1.08 1.56 1.56 0.64
Total non-current assets 9.04 7.65 6.26 8.07
Total Assets 158.25 151.57 359.36 381.23
Accounts Payable 0.65 1.30 1.37 1.94
Accrued Expenses 12.41 14.20 11.92 12.35
Current Revenue (Deferred) 22.38 26.88 17.88 24.07
Total current liabilities 41.03 46.62 34.02 39.86
Non-current Revenue (Deferred) 5.54 1.59 0.98 30.62
Non-current Liabilities (Other) 4.30 4.35 4.41 4.47
Total non-current liabilities 9.84 5.94 5.39 39.30
Total liabilities 50.87 52.56 39.41 79.16
Additional Paid In Capital 789.72 810.84 1,050.04 1,053.13
Common Stock (Net) 0.00 0.00 0.00 0.00
Retained Earnings (682.44) (711.95) (730.20) (750.86)
Common Equity (Total) 107.39 99.01 319.94 302.07
Shareholders Equity (Total) 107.39 99.01 319.94 302.07
Shareholders Equity and Liabilities (Total) 158.25 151.57 359.36 381.23
Shares (Common) 165.07 170.19 217.69 217.90
Shareholders Equity (Tangible) 105.97 97.62 318.59 300.75
Net Debt (143.63) (137.05) (346.71) (331.20)

Fold the line items

In millions of $ except per-share values · columns are period end dates